4
Changes in Ownership
Cryoport, Inc. Filed Acc 0001104659-21-035159
Chief Scientific Officer sold 13,331 shares at an average $55.13 ($734,934)
- Chief Scientific Officer acquired 30,404 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Sawicki Mark W · Chief Scientific Officer
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-03-10 | Exercise or conversion : show line 1 in the form | +11,342 | $3.07 | $34,820 | 30,342 | D |
| 2021-03-10 | Exercise or conversion : show line 2 in the form | +7,231 | $1.87 | $13,522 | 37,573 | D |
| 2021-03-10 | Exercise or conversion : show line 3 in the form | +11,831 | $3.21 | $37,978 | 49,404 | D |
| 2021-03-10 | Sale : show line 4 in the form | −3,974 | $54.65 | $217,166 | 45,430 | D |
| 2021-03-10 | Sale : show line 5 in the form | −9,357 | $55.33 | $517,768 | 36,073 | D |
| Open-market sales · 13,331 sh · avg $55.13 · $734,934 | ||||||
Table II: Derivative
5 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-03-09 | Grant or award : show line 6 in the form Option to purchase common stock | +21,333 | 21,333 | D |
| 2021-03-09 | Grant or award : show line 7 in the form Restricted Stock Rights | +10,667 | 10,667 | D |
| 2021-03-10 | Exercise or conversion : show line 8 in the form Options to purchase common stock | −11,342 | 0 | D |
| 2021-03-10 | Exercise or conversion : show line 9 in the form Options to purchase common stock | −11,831 | 0 | D |
| 2021-03-10 | Exercise or conversion : show line 10 in the form Options to purchase common stock | −7,231 | 0 | D |
Loading xslF345X03/tm219529d2_4seq1.xml…